Knight Therapeutics Inc. (TSX:GUD)

Knight Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 18, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	621	536	541	584	630	696
Market Cap Growth	1.14%	-0.95%	-7.35%	-7.29%	-9.50%	-32.33%
Enterprise Value	609	418	455	466	510	337
Last Close Price	6.23	5.34	5.19	5.18	5.30	5.35
PE Ratio	1621.01	123.63	-	-	40.16	16.54
Forward PE	222.50	157.06	79.24	-	82.43	-
PS Ratio	1.61	1.44	1.65	1.99	2.59	3.49
PB Ratio	0.81	0.67	0.72	0.71	0.75	0.79
P/TBV Ratio	2.15	1.26	1.43	1.44	1.51	1.07
P/FCF Ratio	21.75	15.84	15.45	13.86	15.44	-
P/OCF Ratio	20.42	14.76	15.05	12.97	14.11	-
EV/Sales Ratio	1.58	1.13	1.39	1.59	2.10	1.69
EV/EBITDA Ratio	14.79	7.46	8.55	11.38	15.73	113.34
EV/EBIT Ratio	-	56.47	71.47	-	-	-
EV/FCF Ratio	21.34	12.35	13.01	11.07	12.52	-
Debt / Equity Ratio	0.14	0.06	0.09	0.09	0.05	0.06
Debt / EBITDA Ratio	2.54	0.83	1.24	1.73	1.18	9.99
Debt / FCF Ratio	3.67	1.46	1.98	1.85	1.00	-
Asset Turnover	0.39	0.39	0.33	0.29	0.24	0.17
Inventory Turnover	1.74	2.02	1.91	1.89	1.99	1.85
Quick Ratio	1.46	2.57	2.35	2.08	2.16	4.28
Current Ratio	2.47	3.57	3.20	2.80	2.90	4.84
Return on Equity (ROE)	0.05%	0.56%	-2.14%	-3.58%	1.81%	3.53%
Return on Assets (ROA)	-0.56%	0.48%	0.40%	-1.04%	-0.79%	-1.40%
Return on Capital (ROIC)	-0.66%	0.56%	0.46%	-1.19%	-0.88%	-1.71%
Return on Capital Employed (ROCE)	-	0.90%	0.80%	-	-	-
Earnings Yield	0.06%	0.81%	-3.11%	-5.12%	2.49%	6.05%
FCF Yield	4.60%	6.31%	6.47%	7.22%	6.48%	-2.53%
Buyback Yield / Dilution	2.39%	5.61%	6.46%	7.74%	5.66%	5.82%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.